TIGIT (T-cell immunoreceptor with IgG and ITIM domains), whose expression is inhibited by IFNs80, was recently identified as a cancer stem cell marker in LUAD81 and TIGIT expression on tumor cells was shown to supress CD8 T cells and NK cells82. The gene discussed is CD8A; the disease is neoplasm.